Publications

Our publications

Informed consent and risk communication challenges in antimicrobial clinical trials: a scoping review

BMJ Open

Exploring desirability of outcome ranking and generalised pairwise comparisons as endpoints in serious infections: Post hoc application with the MERINO trial

CMI Communications

Combination Versus Monotherapy for Carbapenem-Resistant Acinetobacter Species Serious Infections: A Prospective IPTW Adjusted Cohort Study

Infectious Diseases and Therapy

Rapid Diagnostic Tests and Antimicrobial Stewardship Programs for the Management of Bloodstream Infection: What Is Their Relative Contribution to Improving Clinical Outcomes? A Systematic Review and Network Meta-analysis

Clinical Infectious Diseases

Concerning the use of aminoglycosides in ventilator-associated pneumonia–Authors' reply

The Lancet Respiratory Medicine

Win Ratio Analyses of Piperacillin-Tazobactam Versus Meropenem for Ceftriaxone-Nonsusceptible Escherichia coli or Klebsiella pneumoniae Bloodstream Infections: Post Hoc Insights From the MERINO Trial

Clinical Infectious Diseases

Global trends in carbapenem- and difficult-to-treat-resistance among World Health Organization priority bacterial pathogens: ATLAS surveillance program 2018-2022

Journal of Global Antimicrobial Resistance

The Rapid Emergence of Hypervirulent Klebsiella Species and Burkholderia pseudomallei as Major Health Threats in Southeast Asia: The Urgent Need for Recognition as Neglected Tropical Diseases

Tropical Medicine and Infectious Disease

Scoping review of risk-scoring tools for early prediction of bloodstream infections caused by carbapenem-resistant Enterobacterales: do we really have a reliable risk-scoring tool?

JAC-Antimicrobial Resistance

Persistence of Detectable Pathogens by Culture-Independent Systems (T2 Magnetic Resonance) in Patients With Bloodstream Infection: Prognostic Role and Possible Clinical Implications

Clinical Infectious Diseases

"Real-World" Evidence, Target Trial Emulation, and Randomized Clinical Trials-Which Data Should Clinicians Rely on When Choosing Antibiotics?

JAMA Network Open

ACORN (A Clinically-Oriented Antimicrobial Resistance Surveillance Network) II: protocol for case based antimicrobial resistance surveillance

Wellcome Open Research

Rapid diagnostics for antibiotic resistance: urgent need for strong clinical evidence

Clinical Infectious Diseases